Skip to content

Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH: A three-way crossover study

Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH: A three-way crossover study - Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020989
Enrollment
15
Registered
2016-02-22
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reflux esophagitis

Interventions

Vonoprazan20mg-(washout period)-Lansoprazole30mg-(washout period)-Famotidine20mg Lansoprazole30mg-(washout period)-Vonoprazan20mg-(washout period)-Famotidine20mg Famotidine20mg-(washout period)-Lansop

Sponsors

Yokohama City University School of Medicine Department of Medical Education
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patient who fills everything the following 1) Helicobacter pylori-negative male Patient 2) Patient of 20 years or more 3) Patient who gives written informed consent

Exclusion criteria

Exclusion criteria: The patient who collides with either the following assumes that it doesn't put it in to the examination 1) Drug allergy 2) Patient who took medicine that influences movement and function of digestive tract such as proton pump inhibitor, H2 blocker, and NSAIDs within 4 weeks

Design outcomes

Primary

MeasureTime frame
intragastric pH by pH meter attached to the antimony pH electrode for 6 hour after administration

Countries

Japan

Contacts

Public ContactHiroshi Iida

Yokohama City University School of Medicine Department of Medical Education

hiro0905@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026